Research papers of the week – October 3, 2022

Canine B Cell Lymphoma- and Leukemia-Derived Extracellular Vesicles Moderate Differentiation and Cytokine Production of T and B Cells In Vitro

Magdalena Żmigrodzka, Olga Witkowska-Pilaszewicz, Rafał Pingwara, Aleksandra Pawlak, Anna Winnicka
International Journal of Molecular Sciences

Ministerial score = 140.0
Journal Impact Factor (2022) = 6.208 (Q1)

international_journal_od_molecular_sciences.jpgExtracellular vesicles (EVs) are formed in physiological and pathological conditions by almost all mammalian cells. They are known as submicron “molecules” that transport and horizontally transfer their cargo from maternal cells to donor cells. Moreover, cancer cells produce tumor-derived EVs (TEVs), which are present in blood of patients with solid tumors and those with hematological malignancies. Their role in evading immune system surveillance and induction of immunosuppression in hematological cancer is limited. According to the authors’ best knowledge, there is no information about the impact of TEVs from canine lymphoma (CLBL-1) and leukemia (CLB70) on lymphocytes isolated from peripheral blood mononuclear cells (PBMCs). In conclusion, we demonstrate in in vitro experiments that CLBL-1 EVs and CLB70 EVs are effectively taken up by T and B lymphocytes. TEVs decrease the percentage of B lymphocytes and increase that of T lymphocytes, and change T cells’ phenotype into the effector memory (EM) or terminally differentiated effector memory (TEMRA) subtype after in vitro co-culturing. Moreover, CLBL70 EVs have pro-tumorogenic properties by inhibiting the production of CD8+IL-17+ cells.

DOI:10.3390/ijms23179831

READ THE PAPER UPWr Base


magnacarta-logo.jpg eua-logo.png hr_logo.png logo.png eugreen_logo_simple.jpg iroica-logo.png bic_logo.png